Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology

Published: Thursday, July 24, 2014
Last Updated: Thursday, July 24, 2014
Bookmark and Share
MuDT™ technology doubles the channel availability of any real-time PCR instrument.

Seegene Inc. has announced “MuDT™” technology, the industry’s first real-time PCR technology that will ignite a paradigm shift in the PCR instrument market.

By doubling the multiplexing capacity of any existing real-time PCR instrument, MuDT™ will maximize the value of the installed base of real-time PCR instruments.

MuDT™ technology will be unveiled at the 2014 Clinical Lab Expo of the American Association for Clinical Chemistry (AACC), held in Chicago from July 29 to 31.

The biotechnology industry has relied on real-time PCR, the gold standard in molecular diagnostics, due to its versatility, speed and ease of use. Despite many attempts over the past 20 years, the biotechnology industry has not made significant advances that satisfy the growing demand for increased multiplexing and target quantification using limited numbers of channels in a single tube.

Even melt curve analysis after amplification has many drawbacks, such as end-point analysis after amplification, extended turnaround time, lack of quantification and melt temperature variation due to target sequence variations on probe binding regions.

MuDT™ technology can be applied to any existing real-time PCR instrument and transforms it into a more powerful system by doubling its multiplexing capacity without upgrading the hardware.

Additional benefits of MuDT™ technology include:

• Easier detection of multiple targets in a single channel without requiring melt curve analysis after amplification.
• SNP genotyping (homozygous wild type or mutant, or heterozygous) in a single channel.
• Identification and quantification of multiple mutations at the same time in a single tube.
• Economical approach for high multiplexing and quantification by doubling channel availability.
• Freedom from well-to-well and instrument-to-instrument variations.

“MuDT™ is an extremely powerful technology that maximizes the usage of any existing real-time PCR instrument and that will re-invigorate the real-time PCR based market," said Dr. Chun, Jong-Yoon, Founder, CTO and CEO of Seegene. “By adopting MuDT™ technology, real-time PCR companies will be able to add great value and competitiveness to their current instruments.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Seegene and Eidia Collaborate
Through this agreement, Eidia gains access to Seegene's portfolio of TOCE™ technology-based multiplexed molecular diagnostic tests for the Japanese diagnostic test market.
Tuesday, July 09, 2013
Seegene Announces Magicplex™ RV Panel Real-Time Test
New multiplex real-time PCR test can simultaneously detect 29 respiratory viruses, including Influenza A subtypes.
Tuesday, November 02, 2010
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos